HeartSciences (HSCSW) Income from Continuing Operations (2021 - 2026)
HeartSciences (HSCSW) reported Income from Continuing Operations of 1990449.0 for Q1 2026, up 21.97% on a YoY basis from 1631887.23 in Q1 2025, and up 15.41% quarter-over-quarter from 2352937.0 in Q4 2025.
HeartSciences (HSCSW) Income from Continuing Operations (2021 - 2026) Analysis & Trends
HeartSciences has reported Income from Continuing Operations for 6 years, with the latest figure at 1990449.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 21.97% year-over-year to 1990449.0; the trailing twelve-month figure through Jan 2026 stood at 8502444.0 (up 1.73% YoY), and the FY2025 full-year result was 8853024.0, down 32.93% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1990449.0, up from 2352937.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1239354.0 in Q1 2022, with the low at 2550949.0 in Q1 2025.
- Historically, Income from Continuing Operations has averaged 1854800.24 across 5 years, with a median of 1900727.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 109.25% — and 2026, when it advanced 21.97%.
- HeartSciences' Income from Continuing Operations stood at 1807710.0 in 2022, then increased by 3.28% to 1748381.0 in 2023, then retreated by 20.26% to 2102631.0 in 2024, then fell by 11.9% to 2352937.0 in 2025, then rose by 15.41% to 1990449.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1990449.0 (Q1 2026), 2352937.0 (Q4 2025), and 2057807.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | HeartSciences | - | - | - | -1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1.99 Mn |
| Oct 31, 2025 | -2.35 Mn |
| Jul 31, 2025 | -2.06 Mn |
| Apr 30, 2025 | -2.10 Mn |
| Jan 31, 2025 | -2.55 Mn |
| Oct 31, 2024 | -2.10 Mn |
| Jul 31, 2024 | -2.10 Mn |
| Apr 30, 2024 | -1.90 Mn |
| Jan 31, 2024 | -1.64 Mn |
| Oct 31, 2023 | -1.75 Mn |
| Jul 31, 2023 | -1.37 Mn |
| Apr 30, 2023 | -1.63 Mn |
| Jan 31, 2023 | -1.31 Mn |
| Oct 31, 2022 | -1.81 Mn |
| Jul 31, 2022 | -1.57 Mn |
| Apr 30, 2022 | -2.05 Mn |
| Jan 31, 2022 | -1.24 Mn |
| Oct 31, 2021 | -1.03 Mn |
| Jul 31, 2021 | -752,051.00 |